Auf dieser Seite
SMMT Summit Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 23, 2026
$16,76
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$12,0752-Wochen-Tief
$29,2352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$13.29B
P/E
-11.6
EPS
$-1.44
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$12–$29
Analystenbewertung
BUY
Kursziel
$29
P/E
-11.6
ROE
-235.1%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SMMT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$16.75
Marktkapitalisierung (MRQ)
$13.29B
P/E
-11.6
EPS
$-1.44
Umsatz
$0
ROE
-235.1%
52W-Spanne
$12–$29
SMMT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02019-01-31 → 2024-12-31
EPS$-1.442019-01-31 → 2025-12-31
Freier Cashflow$-324M2020-12-31 → 2025-12-31
Nettogewinnmarge·2020-12-31 → 2022-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SMMT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -11.65-Jahres-Durchschnitt ≈-17.3 | ≈-17.3 | · | · | |
| K/B (MRQ) | 21.15-Jahres-Durchschnitt ≈17.7 | ≈17.7 | 11.3 | Überbewertet | |
| Kurs / FCF (TTM) | -28.95-Jahres-Durchschnitt ≈-36.6 | ≈-36.6 | · | · | |
| Kurs / Cashflow (TTM) | -29.05-Jahres-Durchschnitt ≈-36.7 | ≈-36.7 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 19.85-Jahres-Durchschnitt ≈17.9 | ≈17.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SMMT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -181.9%5-Jahres-Durchschnitt ≈-99.1% | ≈-99.1% | 4.8% | Schwach | |
| ROE | -235.1%5-Jahres-Durchschnitt ≈-227.9% | ≈-227.9% | 16.1% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SMMT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 7.05-Jahres-Durchschnitt ≈10.0 | ≈10.0 | 2.7 | Starke Liquidität | |
| Quick Ratio | 9.85-Jahres-Durchschnitt ≈8.1 | ≈8.1 | 1.8 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | SMMT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-87.6%
Nächster Bericht
Okt 19, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.28 | $-0.28 | 1.7% |
| 31. März 2026 | Mai 7, 2026 | $-0.24 | $-0.18 | -33.3% |
| 31. Dezember 2025 | $-0.29 | $-0.07 | -342.1% | |
| 30. September 2025 | $-0.31 | $-0.13 | -130.5% | |
| 30. Juni 2025 | $-0.12 | $-0.10 | -24.5% | |
| 31. März 2025 | $-0.09 | $-0.09 | 3.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $705.0K | $2M | $860.0K | $743.0K | |
| R&D Expense | · | · | $59M | $52M | $85M | $53M | $40M | |
| SG&A Expense | $557M | $60M | $29M | $27M | $24M | $19M | $11M | |
| Operating Expenses | $1.09B | $226M | $610M | $87M | $109M | $73M | $51M | |
| Operating Income | · | $-226M | $-610M | $-72M | $-86M | $-53M | $-27M | |
| Interest Expense | · | · | · | $4M | $242.0K | $255.0K | $291.0K | |
| Interest Income | · | · | · | $2M | $0 | $4.0K | $5.0K | |
| Other Non-op | $-53.0K | $0 | $-252.0K | $304.0K | $-39.0K | $283.0K | $-2M | |
| Pretax Income | $-1.08B | $-221M | $-615M | $-79M | $-89M | $-53M | $-29M | |
| Income Tax | $0 | $0 | $0 | · | $0 | $-213.0K | $36.0K | |
| Net Income | $-1.08B | $-221M | $-615M | $-79M | $-89M | $-53M | $-29M | |
| EPS (Basic) | $-1.44 | $-0.31 | $-0.99 | $-0.41 | $-0.67 | $-0.76 | $-0.89 | |
| EPS (Diluted) | $-1.44 | $-0.31 | $-0.99 | $-0.41 | $-0.67 | $-0.76 | $-0.89 | |
| Shares (Basic) | 747,702,265 | 718,541,896 | 619,646,180 | 193,336,063 | 131,714,225 | 69,524,148 | 32,829,003 | |
| Shares (Diluted) | 747,702,265 | 718,541,896 | 619,646,180 | 193,336,063 | 131,714,225 | 69,524,148 | 32,829,003 | |
| EBITDA | · | $-226M | $-610M | $-72M | $-86M | $-53M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $225M | $105M | $71M | $349M | $72M | $66M | $64M | |
| Short-term Investments | $488M | $307M | $115M | $0 | · | · | · | |
| Receivables | · | · | $0 | $349.0K | $1M | $331.0K | $541.0K | |
| Prepaid Expense | $7M | $11M | $3M | $2M | $7M | $10M | $9M | |
| Other Current Assets | · | · | $181.0K | $486.0K | $1M | $2M | $1M | |
| Current Assets | $720M | $424M | $190M | $657M | $97M | $88M | $80M | |
| PP&E (Net) | $1M | $254.0K | $204.0K | $906.0K | $694.0K | $725.0K | $518.0K | |
| PP&E (Gross) | · | $1M | $1M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | · | $1M | $1M | $1M | $1M | $1M | $1M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | · | $0 | $0 | $0 | $10M | $12M | $13M | |
| Other Non-current Assets | $7M | $3M | $4M | $577.0K | $170.0K | $0 | · | |
| Total Assets | $751M | $436M | $203M | $664M | $113M | $102M | $96M | |
| Accounts Payable | $20M | $5M | $3M | $355.0K | $4M | $6M | $4M | |
| Accrued Liabilities | $32M | $20M | $9M | $11M | $7M | $3M | $6M | |
| Short-term Debt | · | · | $0 | $20M | · | · | · | |
| Current Liabilities | $73M | $42M | $20M | $39M | $26M | $20M | $14M | |
| Capital Leases | $18M | $3M | $3M | $3M | $2M | $75.0K | $422.0K | |
| Deferred Tax | · | · | · | · | · | · | $2M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $1M | $3M | $3M | $3M | |
| Total Liabilities | $92M | $47M | $125M | $538M | $30M | $23M | $17M | |
| Total Debt | · | · | $0 | · | · | · | · | |
| Common Stock | $8M | $7M | $7M | $2M | $980.0K | $826.0K | $672.0K | |
| Paid-in Capital | $2.95B | $1.60B | $1.07B | $505M | $384M | $293M | $241M | |
| Retained Earnings | $-2.29B | $-1.21B | $-993M | $-378M | $-300M | $-211M | $-158M | |
| AOCI | $-3M | $-2M | $-2M | $-2M | $-2M | $-4M | $-5M | |
| Stockholders' Equity | $659M | $389M | $78M | $127M | $83M | $79M | $79M | |
| Liabilities + Equity | $751M | $436M | $203M | $664M | $113M | $102M | $96M | |
| Shares Outstanding | 775,371,200 | 737,626,004 | 701,660,053 | 211,091,425 | 98,039,540 | 82,575,064 | 67,178,054 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $732M | $51M | $14M | $12M | $13M | $2M | $845.0K | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | |
| Amort. of Intangibles | · | $0 | $0 | $914.0K | $1M | $1M | $970.0K | |
| Operating Cash Flow | $-323M | $-142M | $-77M | $-42M | $-73M | $-48M | $-21M | |
| CapEx | $657.0K | $139.0K | $128.0K | $624.0K | $306.0K | $421.0K | $205.0K | |
| Investing Cash Flow | $-174M | $-205M | $-588M | $-624.0K | $-306.0K | $-421.0K | $-341.0K | |
| Stock Issued | · | · | $105M | $100M | $75M | $50M | $50M | |
| Net Stock Activity | · | · | $105M | $100M | $75M | $50M | · | |
| Dividends Paid | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $618M | $381M | $87M | $620M | $78M | $51M | $50M | |
| Net Change in Cash | $120M | $34M | $-577M | $577M | $5M | $3M | $29M | |
| Taxes Paid | $0 | $0 | $52.0K | $0 | $7.0K | $-70.0K | $63.0K | |
| Free Cash Flow | $-324M | $-142M | $-77M | $-42M | $-73M | $-49M | · | |
| Levered FCF | · | · | · | · | $-73M | $-49M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -10225.4% | -4764.3% | -6185.2% | · | |
| Net Margin | · | · | · | -11174.8% | -4897.8% | -6127.6% | · | |
| Pretax Margin | · | · | · | -11174.8% | -4897.8% | -6152.3% | · | |
| EBITDA Margin | · | · | · | -10225.4% | -4764.3% | -6185.2% | · | |
| ROA | -181.9% | -69.3% | -141.8% | -20.3% | -82.1% | -53.0% | · | |
| ROE | -235.1% | -53.5% | -694.6% | -60.6% | -95.5% | -89.3% | · | |
| ROIC | · | · | · | · | -103.5% | -66.7% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.9 | 10.2 | 9.3 | 16.9 | 3.8 | 4.4 | · | |
| Quick Ratio | 9.8 | 9.9 | 9.1 | 9.0 | 2.9 | 3.4 | · | |
| Debt / Equity | · | · | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | -16.4 | -306.7 | -208.6 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | 0.0 | 0.8 | 2.0 | 2.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.85 | $0.53 | $0.11 | $0.60 | $0.85 | $0.96 | · | |
| Revenue / Share | · | $0.00 | $0.00 | $0.00 | $0.02 | $0.01 | · | |
| Cash Flow / Share | $-0.43 | $-0.20 | $-0.12 | $-0.22 | $-0.79 | $-0.69 | · | |
| Cash / Share | $0.29 | $0.14 | $0.10 | $1.65 | $0.73 | $0.80 | · | |
| EPS (TTM) | $-1.44 | $-0.31 | $-0.99 | $-0.41 | $-0.67 | $-0.76 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -61.0% | 110.3% | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | $0 | $705.0K | $2M | $860.0K | · | |
| Net Income TTM | $-1.08B | $-221M | $-615M | $-79M | $-89M | $-53M | · | |
| Market Cap | $13.56B | $13.16B | $1.83B | $897M | $264M | $388M | · | |
| Enterprise Value | · | · | $1.65B | · | · | · | · | |
| P/E | -12.1 | -57.6 | -2.6 | -10.4 | -4.0 | -6.2 | · | |
| P/S | · | · | · | 1272.5 | 145.8 | 451.3 | · | |
| P/B | 20.6 | 33.9 | 23.6 | 7.1 | 3.2 | 4.9 | · | |
| P / Tangible Book | 20.6 | 34.0 | 24.2 | 7.2 | 3.7 | 5.9 | · | |
| P / Cash Flow | -42.0 | -92.6 | -23.9 | -21.6 | -3.6 | -8.1 | · | |
| P / FCF | -41.9 | -92.5 | -23.8 | -21.3 | -3.6 | -8.0 | · | |
| EV / EBITDA | · | · | -2.7 | · | · | · | · | |
| EV / FCF | · | · | -21.4 | · | · | · | · | |
| Dividend Yield | · | · | · | · | · | 0.00% | · | |
| Earnings Yield | -8.2% | -1.7% | -37.9% | -9.7% | -24.9% | -16.2% | · | |
| Payout Ratio | · | · | · | · | · | 0.00% | · | |
| Annual Payout | · | · | · | · | · | $0 | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $220.0K | $235.0K | |
| R&D Expense | $158M | $133M | · | · | $208M | $51M | · | · | · | $31M | $15M | $9M | $10M | · | $17M | $9M | |
| SG&A Expense | $63M | $63M | $78M | $103M | $360M | $16M | $14M | $21M | $14M | $12M | $5M | $6M | $7M | $8M | $6M | $7M | |
| Operating Expenses | $220M | $195M | $225M | $234M | $568M | $67M | $66M | $58M | $60M | $42M | $21M | $16M | $538M | $21M | $23M | $16M | |
| Operating Income | · | · | · | · | · | · | · | $-58M | $-60M | $-42M | $-20M | $-16M | $-537M | $-20M | $-17M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | $8M | · | $692.0K | $653.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Other Non-op | $500.0K | $6M | $-4M | $0 | $-53.0K | $4M | $-2M | $0 | $0 | $2M | $-64.0K | $-5.0K | $417.0K | $289.0K | $46.0K | $-14.0K | |
| Net Income | $-216M | $-189M | $-219M | $-232M | $-566M | $-63M | $-61M | $-56M | $-60M | $-43M | $-21M | $-15M | $-542M | $-19M | $-21M | $-17M | |
| EPS (Basic) | $-0.28 | $-0.24 | $-0.28 | $-0.31 | $-0.76 | $-0.09 | $-0.08 | $-0.08 | $-0.09 | $-0.06 | $-0.03 | $-0.02 | $-1.43 | $-0.04 | $-0.10 | $-0.12 | |
| EPS (Diluted) | $-0.28 | $-0.24 | $-0.28 | $-0.31 | $-0.76 | $-0.09 | $-0.08 | $-0.08 | $-0.09 | $-0.06 | $-0.03 | $-0.02 | $-1.43 | $-0.04 | $-0.10 | $-0.12 | |
| Shares (Basic) | 778,184,568 | 775,458,141 | · | 743,415,917 | 742,615,007 | 738,076,003 | · | 726,656,045 | 707,904,643 | 701,785,250 | 697,739,477 | 697,685,365 | 378,163,980 | · | 208,909,351 | 140,114,997 | |
| Shares (Diluted) | 778,184,568 | 775,458,141 | · | 743,415,917 | 742,615,007 | 738,076,003 | · | 726,656,045 | 707,904,643 | 701,785,250 | 697,739,477 | 697,685,365 | 378,163,980 | · | 208,909,351 | 140,114,997 | |
| EBITDA | · | · | · | · | · | · | · | $-58M | $-60M | $-42M | $-20M | $-16M | $-537M | · | $-17M | $-13M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $419M | $107M | $225M | $239M | $298M | $212M | $105M | $94M | $28M | $61M | $24M | $42M | $71M | $349M | $122M | $57M | |
| Short-term Investments | $271M | $492M | $488M | $0 | $0 | $150M | $307M | $393M | $297M | $95M | $175M | $173M | $171M | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $140.0K | $238.0K | |
| Prepaid Expense | $30M | $18M | $7M | $8M | $11M | $9M | $11M | $2M | $2M | $5M | $5M | $6M | $1M | · | $2M | $5M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | $120.0K | $2M | $409.0K | · | $428.0K | $2M | |
| Current Assets | $721M | $617M | $720M | $246M | $309M | $371M | $424M | $490M | $329M | $163M | $205M | $228M | $248M | · | $137M | $79M | |
| PP&E (Net) | $2M | $2M | $1M | $810.0K | $690.0K | $652.0K | $254.0K | $265.0K | $223.0K | $181.0K | $229.0K | $225.0K | $412.0K | · | $930.0K | $1M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $8M | $9M | |
| Other Non-current Assets | $8M | $8M | $7M | $7M | $7M | $4M | $3M | $2M | $2M | $2M | $4M | $254.0K | $156.0K | · | $140.0K | $179.0K | |
| Total Assets | $752M | $648M | $751M | $262M | $324M | $384M | $436M | $503M | $342M | $177M | $218M | $237M | $255M | · | $155M | $96M | |
| Accounts Payable | $23M | $28M | $20M | $22M | $23M | $5M | $5M | $3M | $3M | $6M | $3M | $987.0K | $710.0K | · | $1M | $4M | |
| Accrued Liabilities | $65M | $44M | $32M | $27M | $26M | $21M | $20M | $18M | $12M | $7M | $4M | $4M | $12M | · | $11M | $6M | |
| Short-term Debt | · | · | · | · | · | · | · | $24M | $100M | · | $100M | $0 | · | · | · | · | |
| Current Liabilities | $104M | $83M | $73M | $65M | $60M | $35M | $42M | $59M | $140M | $23M | $114M | $12M | $17M | · | $17M | $15M | |
| Capital Leases | $17M | $17M | $18M | $3M | $2M | $3M | $3M | $4M | $5M | $6M | $4M | $4M | $2M | · | $3M | $1M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $1M | $2M | $1M | · | $2M | $3M | |
| Total Liabilities | $122M | $102M | $92M | $69M | $65M | $39M | $47M | $65M | $147M | $133M | $119M | $118M | $121M | · | $22M | $44M | |
| Total Debt | · | · | · | · | · | · | · | $24M | $100M | · | $100M | $0 | · | · | · | · | |
| Common Stock | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | · | $2M | $981.0K | |
| Paid-in Capital | $3.32B | $3.02B | $2.95B | $2.26B | $2.10B | $1.62B | $1.60B | $1.59B | $1.29B | $1.08B | $1.05B | $1.05B | $1.05B | · | $494M | $391M | |
| Retained Earnings | $-2.70B | $-2.48B | $-2.29B | $-2.07B | $-1.84B | $-1.28B | $-1.21B | $-1.15B | $-1.10B | $-1.04B | $-957M | $-935M | $-921M | · | $-359M | $-338M | |
| AOCI | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | · | $-3M | $-3M | |
| Stockholders' Equity | $630M | $546M | $659M | $192M | $259M | $344M | $389M | $438M | $195M | $44M | $99M | $120M | $133M | $127M | $133M | $51M | |
| Liabilities + Equity | $752M | $648M | $751M | $262M | $324M | $384M | $436M | $503M | $342M | $177M | $218M | $237M | $255M | · | $155M | $96M | |
| Shares Outstanding | 793,120,362 | 776,017,474 | 775,371,200 | 744,442,533 | 742,806,672 | 741,609,390 | 737,626,004 | 737,094,965 | 724,320,201 | 701,974,596 | 697,851,308 | 697,685,365 | 697,685,365 | 211,091,425 | 201,321,175 | 98,122,356 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $69M | $73M | $112M | $131M | $479M | $11M | $11M | $19M | $11M | $10M | $705.0K | $2M | $3M | $3M | $3M | $2M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $217.0K | $217.0K | $232.0K | |
| Operating Cash Flow | $-141M | $-122M | $-102M | $-93M | $-67M | $-61M | $-49M | $-30M | $-33M | $-30M | $-15M | $-29M | $-13M | $5M | $-9M | $-19M | |
| CapEx | $909.0K | $245.0K | $164.0K | $71.0K | $0 | $422.0K | $14.0K | $58.0K | $63.0K | $4.0K | $53.0K | $20.0K | $53.0K | $-10.0K | $-20.0K | $293.0K | |
| Investing Cash Flow | $223M | $-238.0K | $-485M | $-71.0K | $151M | $160M | $83M | $-109M | $-200M | $20M | $-3M | $207.0K | $-645M | $10.0K | $20.0K | $-293.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $105M | · | $100M | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | $105M | · | · | · | |
| Financing Cash Flow | $231M | $4M | $574M | $34M | $2M | $8M | $-24M | $204M | $200M | $485.0K | $229.0K | $-80.0K | $80M | $520M | $75M | $0 | |
| Net Change in Cash | $313M | $-119M | $-13M | $-59M | $86M | $107M | $11M | $65M | $-33M | $-10M | $-18M | $-29M | $-578M | $527M | $65M | $-20M | |
| Taxes Paid | · | · | · | · | · | · | $0 | $0 | · | · | $0 | · | · | $0 | $0 | · | |
| Free Cash Flow | · | $-123M | · | · | · | $-62M | · | · | · | $-30M | · | · | $-13M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -7700.0% | -5400.8% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -9720.4% | -7136.6% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -7700.0% | -5400.8% | |
| ROA | -40.1% | -36.7% | · | -60.6% | -169.9% | -22.4% | · | -15.6% | -20.8% | -20.1% | -11.4% | -8.8% | -292.1% | · | -15.1% | -13.9% | |
| ROE | -48.5% | -42.5% | · | -73.6% | -248.9% | -32.4% | · | -20.9% | -38.4% | -48.9% | -18.3% | -17.2% | -548.2% | · | -18.2% | -19.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 7.4 | · | 3.8 | 5.1 | 10.6 | · | 8.3 | 2.3 | 7.0 | 1.8 | 19.1 | 14.2 | · | 8.2 | 5.2 | |
| Quick Ratio | 6.7 | 7.2 | · | 3.7 | 4.9 | 10.4 | · | 8.3 | 2.3 | 6.7 | 1.7 | 18.0 | 13.9 | · | 7.3 | 3.8 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.5 | · | 1.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -64.5 | · | -24.5 | -19.4 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.79 | $0.70 | · | $0.26 | $0.35 | $0.46 | · | $0.59 | $0.27 | $0.06 | $0.14 | $0.17 | $0.19 | · | $0.66 | $0.52 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | |
| Cash Flow / Share | · | $-0.16 | · | · | · | $-0.08 | · | · | · | $-0.04 | · | · | $-0.03 | · | · | · | |
| Cash / Share | $0.53 | $0.14 | · | $0.32 | $0.40 | $0.29 | · | $0.13 | $0.04 | $0.09 | $0.03 | $0.06 | $0.10 | · | $0.61 | $0.58 | |
| EPS (TTM) | $-1.11 | $-1.59 | · | $-1.24 | $-1.01 | $-0.34 | · | $0.26 | $0.31 | $0.38 | $-1.52 | $-1.59 | $-1.69 | · | $-0.36 | $-0.46 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $220.0K | $455.0K | · | $956.0K | $2M | |
| Net Income TTM | $-856M | $-1.21B | · | $-922M | $-746M | $-241M | · | $-197M | $-162M | $-116M | $-598M | $-598M | $-600M | · | $-87M | $-85M | |
| Market Cap | $11.56B | $14.71B | · | $15.38B | $15.81B | $14.31B | · | $16.14B | $5.65B | $2.91B | $1.30B | $1.75B | $1.22B | · | $240M | $98M | |
| Enterprise Value | · | · | · | · | · | · | · | $15.68B | $5.42B | · | $1.21B | $1.54B | · | · | · | · | |
| P/E | -13.1 | -11.9 | · | -16.7 | -21.1 | -56.7 | · | 84.2 | 25.2 | 10.9 | -1.2 | -1.6 | -1.0 | · | -3.3 | -2.2 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 7960.0 | 2683.4 | · | 250.6 | 48.0 | |
| P/B | 18.3 | 27.0 | · | 80.0 | 60.9 | 41.5 | · | 36.9 | 29.0 | 65.7 | 13.1 | 14.6 | 9.1 | · | 1.8 | 1.9 | |
| P / Tangible Book | 18.4 | 27.0 | · | 80.8 | 61.4 | 41.8 | · | 37.0 | 29.2 | 68.6 | 13.4 | 14.9 | 9.3 | · | 1.9 | 2.4 | |
| P / Cash Flow | · | -120.3 | · | · | · | -233.9 | · | · | · | -96.4 | · | · | -93.0 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 6982.6 | · | · | · | · | |
| Earnings Yield | -7.6% | -8.4% | · | -6.0% | -4.8% | -1.8% | · | 1.2% | 4.0% | 9.2% | -81.3% | -63.3% | -96.6% | · | -30.2% | -46.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | · | $0 | $0 | $705.0K | $2M |
| Betriebsgewinnmarge % | · | · | · | -10225.4% | -4764.3% |
| Nettoergebnis | $-1.08B | $-221M | $-615M | $-79M | $-89M |
| Verwässerte EPS | $-1.44 | $-0.31 | $-0.99 | $-0.41 | $-0.67 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | · | · |
| Liquiditätsgrad | 9.9 | 10.2 | 9.3 | 16.9 | 3.8 |
| Quick Ratio | 9.8 | 9.9 | 9.1 | 9.0 | 2.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-324M | $-142M | $-77M | $-42M | $-73M |
Institutionelle Eigentümer (13F) 280 Einreicher · $2.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
280
Gehaltener Wert
$2.2B
Neue Positionen
64
Geschlossene Positionen
34
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 64 (+1 vs. Vorquartal) | 34 (-1 vs. Vorquartal) | 106 (+21 vs. Vorquartal) | 58 (+5 vs. Vorquartal) | +20.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $477.697.090 | 32.786.348 | 21,47% | Aktien |
| VANGUARD GROUP INC | $195.489.577 | 11.177.220 | 8,79% | Aktien |
| FMR LLC | $146.340.308 | 10.043.947 | 6,58% | Aktien |
| STATE STREET CORP | $138.951.118 | 9.536.796 | 6,25% | Aktien |
| BlackRock, Inc. | $138.838.127 | 9.529.041 | 6,24% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $83.551.432 | 5.734.484 | 3,76% | Aktien |
| UBS Group AG | $76.256.437 | 5.233.798 | 3,43% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $73.464.708 | 5.042.190 | 3,30% | Aktien |
| GOLDMAN SACHS GROUP INC | $65.760.228 | 4.513.399 | 2,96% | Aktien |
| Point72 Asset Management, L.P. | $53.876.990 | 3.697.803 | 2,42% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $49.950.115 | 3.427.263 | 2,25% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $34.226.110 | 2.349.081 | 1,54% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $28.988.341 | 1.989.591 | 1,30% | Aktien |
| Balyasny Asset Management L.P. | $27.744.981 | 1.904.254 | 1,25% | Aktien |
| CITADEL ADVISORS LLC | $25.143.682 | 1.725.716 | 1,13% | Aktien |
| Aberdeen Group plc | $24.676.131 | 1.693.626 | 1,11% | Aktien |
| Squarepoint Ops LLC | $23.177.024 | 1.590.736 | 1,04% | Aktien |
| MORGAN STANLEY | $21.126.777 | 1.450.019 | 0,95% | Aktien |
| NORGES BANK | $20.143.302 | 1.382.519 | 0,91% | Aktien |
| Logos Global Management LP | $19.669.500 | 1.350.000 | 0,88% | Aktien |
| Octagon Capital Advisors LP | $18.212.500 | 1.250.000 | 0,82% | Aktien |
| D. E. Shaw & Co., Inc. | $18.118.611 | 1.243.556 | 0,81% | Aktien |
| Kynam Capital Management, LP | $17.484.000 | 1.200.000 | 0,79% | Aktien |
| Pictet Asset Management Holding SA | $16.434.565 | 1.134.299 | 0,74% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.161.044 | 1.109.200 | 0,73% | Verkaufsoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14.232.719 | 976.851 | 0,64% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $14.083.143 | 966.585 | 0,63% | Aktien |
| APEIRON CAPITAL Ltd | $14.014.388 | 961.866 | 0,63% | Aktien |
| BANK OF AMERICA CORP /DE/ | $12.602.803 | 864.983 | 0,57% | Aktien |
| DIADEMA PARTNERS LP | $12.533.114 | 860.200 | 0,56% | Kaufoption |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $11.970.990 | 835.963 | 0,54% | Aktien |
| LMR Partners LLP | $11.953.228 | 820.400 | 0,54% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.226.185 | 770.500 | 0,50% | Kaufoption |
| Rock Springs Capital Management LP | $10.417.550 | 715.000 | 0,47% | Aktien |
| CITIGROUP INC | $10.402.980 | 714.000 | 0,47% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $10.151.123 | 696.714 | 0,46% | Aktien |
| CITADEL ADVISORS LLC | $9.352.483 | 641.900 | 0,42% | Kaufoption |
| NORTHERN TRUST CORP | $9.234.379 | 633.794 | 0,42% | Aktien |
| MARSHALL WACE, LLP | $8.409.659 | 577.190 | 0,38% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $7.899.533 | 542.178 | 0,36% | Aktien |
| Candriam S.C.A. | $7.750.071 | 532.432 | 0,35% | Aktien |
| Cutter Capital Management, LP | $7.716.000 | 400.000 | 0,35% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.595.909 | 521.339 | 0,34% | Aktien |
| CITADEL ADVISORS LLC | $7.394.275 | 507.500 | 0,33% | Verkaufsoption |
| Elmind Capital, LP | $7.194.957 | 493.820 | 0,32% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $6.438.979 | 441.934 | 0,29% | Aktien |
| Bank of New York Mellon Corp | $6.284.022 | 431.299 | 0,28% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $6.280.078 | 431.028 | 0,28% | Aktien |
| TD Asset Management Inc | $6.208.044 | 426.084 | 0,28% | Aktien |
| Invesco Ltd. | $6.073.461 | 416.847 | 0,27% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ROBERT W. DUGGAN ×14 Einreichungen | 13. September 2024 | · | Erste Einreichung | · | SEC |
| MAHKAM ZANGANEH, MAHKAM ZANGANEH REVOCABLE TRUST, SHAUN ZANGANEH IRREVOCABLE TRUST ×5 Einreichungen | 13. März 2023 | · | Erste Einreichung | · | SEC |
| Lansdowne Partners (UK) LLP, Lansdowne Developed Markets Master Fund Limited ×8 Einreichungen | 17. Juni 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 19 Insider · 9 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mahkam Zanganeh | Co-Chief Executive Officer | 12. Juni 2026 P | 573.883.879 | 3 | 0 | $51.947.183 |
| Robert W. Duggan | Co-Chief Executive Officer | 12. Juni 2026 P | 573.883.879 | 3 | 0 | $51.947.183 |
| Manmeet Singh Soni | COO and CFO | 4. Juni 2026 P | 3.123.603 | 2 | 0 | $722.250 |
| Ankur Dhingra | Chief Financial Officer | 26. März 2024 P | 354.958 | 0 | 0 | $0 |
| Donaldson Michael Paul | Chief Financial Officer | 19. Februar 2021 D | · | 0 | 0 | $0 |
| Bhaskar Anand | Chief Accounting Officer | 8. Januar 2026 A | 159.751 | 0 | 0 | $0 |
| Jeffrey R Maranian | VP Corporate Controller | 15. Dezember 2021 A | · | 0 | 0 | $0 |
| David Jonathan Powell | Chief Scientific Officer | 30. November 2020 X | 0 | 0 | 0 | $0 |
| Camilla Graham | Chief Clinical Affairs Officer | 4. Oktober 2020 A | · | 0 | 0 | $0 |
| Yu Xia | Direktor | 2. Januar 2026 A | 32.057.147 | 1 | 0 | $9.999.983 |
| Alessandra Cesano | Direktor | 2. Januar 2026 A | · | 0 | 0 | $0 |
| Kenneth A Clark | Direktor | 2. Januar 2026 A | · | 0 | 0 | $0 |
| Robert F. Booth | Direktor | 2. Januar 2026 A | · | 0 | 0 | $0 |
| Jeff Huber | Direktor | 2. Januar 2026 A | 44.052 | 0 | 0 | $0 |
| Mostafa Ronaghi | Direktor | 2. Januar 2026 A | · | 0 | 0 | $0 |
| Ujwala Mahatme | Direktor | 2. Januar 2024 A | · | 0 | 0 | $0 |
| Urte Gayko | Direktor | 25. April 2022 A | · | 0 | 0 | $0 |
| Rainer M Erdtmann | Direktor | 19. Februar 2021 A | · | 0 | 0 | $0 |
| Luhua Wang | · | 28. Februar 2021 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 36 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,88% | 56.422 SH | 1. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,67% | 252.586 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,62% | 22.185 NS | 31. Juli 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,39% | 269.877 SH | 1. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,19% | 3.451 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,17% | 1.027.519 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 44.387 SH | 1. Oktober 2026 | Täglich |
| IWP · iShares Trust | 0,07% | 769.118 SH | 11. September 2026 | Täglich |
| IQSM · New York Life Investments ETF Trust | 0,06% | 14.813 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,04% | 1.691.686 SH | 19. August 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,04% | 19.071 NS | 31. Juli 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 58.622 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,04% | 78.876 SH | 11. September 2026 | Täglich |
| SMMD · iShares Trust | 0,03% | 71.619 SH | 11. September 2026 | Täglich |
| IMCG · iShares Trust | 0,03% | 72.377 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.777.877 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 397.116 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 9.690 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 2.673.084 SH | 19. August 2026 | Täglich |
| IWR · iShares Trust | 0,02% | 548.846 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,02% | 15.508 SH | 11. September 2026 | Täglich |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 215.152 SH | 19. August 2026 | Täglich |
| ILCG · iShares Trust | 0,01% | 13.082 SH | 11. September 2026 | Täglich |
| IWF · iShares Trust | 0,01% | 507.521 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 217.652 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,00% | 6.342 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 5.281 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,00% | 2.183 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,00% | 80.930 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 32.032 SH | 11. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,00% | 12.006 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.708.976 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 110.173 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,00% | 23.019 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.466 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,00% | 30.667 SH | 19. August 2026 | Täglich |
SMMT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 24 Analysten
KAUF
Median-Ziel
$32.79
+95,7%
5 20,8%
Starker Kauf
11 45,8%
Kauf
8 33,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
13 Analysten · 2026-09-28Mittelwert-Ziel $28.65 +71,0%
Jetzt
Aktueller Preis $16.75
Tief$10.77
Mittelwert$28.65
Hoch$40.84
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SMMT | $13.56B | -12.1 | · | · | -235.1% | · |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | · |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | · |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | · |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | · |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | · |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | · |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | · |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 23, 2026